Donation of Human Biological Materials in the European Union: Commodifying Solidarity in the Era of the Biotechnological Revolution?

References

• American Medical Association, Commercial Use of Human Biological Materials, Code of Medical Ethics Opinion 7.3.9. Available from: https://www.ama-assn.org/delivering-care/ethics/commercial-use-human-biological-materials [Accessed 8 Oct 2019].
   Google Scholar
• Charter of Fundamental Rights of the European Union. OJ C 364, 18.12.2000.
   Google Scholar
• Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. OJ L 38, 09.02.2006, p. 40–52.
   Google Scholar
• Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. OJ L 294, 25.10.2006, p. 32–50.
   Google Scholar
• Convention on Human Rights and Biomedicine (CETS No. 164), Article 21. Available from: www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164 [Accessed 8 Oct 2019].
   Google Scholar
• Council of Europe Explanatory Report to the Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine of 4 April 1997. Available from: http://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=09000016800ccde5 [Accessed 8 Oct 2019].
   Google Scholar
• Council of Europe Guide for the implementation of the principle of prohibition of financial gain with respect to the human body and its parts from living or deceased donors. Available from: https://rm.coe.int/guidefinancial-gain/16807bfc9a [Accessed 8 Oct 2019].
   Google Scholar
• Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. OJ L 102, 31.03.2004, p. 48–58.
   Google Scholar
• Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions. OJ L 213, 06.07.1998, p. 13–21.
   Google Scholar
• Galloux, J.C., 1998. La protection juridique de la matière biologique en droit français. Revue de droit international et de droit comparé, 50 (2), 491–512. doi: 10.3406/ridc.1998.1173
   Google Scholar
• Lenk, C. and Beier, K., 2012. Is the commercialisation of human tissue and body material forbidden in the countries of the European Union? Journal of medical ethics, 38, 342–346. doi: 10.1136/jme.2010.038760
   PubMed Web of Science ®Google Scholar
• Mahalatchimy, A., et al., 2011. Does the French Bioethics Law create a ‘moral exception’ to the use of human cells for health? A legal and organisational issue. Dilemata, 7, 17–37.
   Google Scholar
• Ministerial Decree of 12 April 2012. Modalità transitorie per l’immissione in commercio dei medicinali emoderivati prodotti dal plasma umano raccolto sul territorio nazionale. GU n.147 of 26 June 2012.
   Google Scholar
• Ministerial Decree of 2 November 2015. Disposizioni relative ai requisiti di qualità e sicurezza del sangue e degli emocomponenti. GU n. 300 of 28 December 2015, suppl. ord. n. 69.
   Google Scholar
• Nuffield Council on Bioethics, 2011. Human bodies: donation for medicine and research. London: Nuffield Council on Bioethics.
   Google Scholar
• Parry, B., 2008. Entangled exchange: Reconceptualising the characterisation and practice of bodily commodification. Geoforum, 39, 1133–1144. doi: 10.1016/j.geoforum.2007.02.001
   Web of Science ®Google Scholar
• Petrini, C., et al., 2011. Collection, storage and allogeneic use of cord blood: informed consent form used by the Italian biobank network. Biopreservation and biobanking, 9 (3), 273–278. doi: 10.1089/bio.2011.0013
   PubMed Web of Science ®Google Scholar
• Pirnay, P.J., et al., 2010. Human cells and tissues: the need for a global ethical framework. Bulletin of the World Health Organization, 88, 870–872. doi: 10.2471/BLT.09.074542
   PubMed Web of Science ®Google Scholar
• Pirnay, P.J., et al., 2012. Beware of the commercialization of human cells and tissues: situation in the European Union. Cell and tissue banking, 13 (3), 487–498. doi: 10.1007/s10561-012-9323-3
   PubMed Web of Science ®Google Scholar
• Pirnay, P.J., et al., 2015. Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium. EMBO reports, 16 (5), 557–562. doi: 10.15252/embr.201540070
   PubMedGoogle Scholar
• Reflection paper on classification of advanced therapy medicinal products of 21 May 2015 EMA/CAT/600280/2010 rev.1 Committee for Advanced Therapies (CAT). Available from: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/advanced-therapies/advanced-therapy-classification [Accessed 8 Oct 2019].
   Google Scholar
• Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products. OJ L 324, 13.11.2007, p.121–137.
   Google Scholar
• Resta, G., 2011. La disposizione del corpo. Regole di appartenenza e circolazione. In: S. Rodotà, P. Zatti, and Trattato di Biodiritto, eds. Vol. II, 1, Il governo del corpo. Milano: Giuffrè, 805–844.
   Google Scholar
• Riva, L., Floridia, G. and Petrini, C., 2018. Ethical and legal issues of cord blood stem cell banking. In: P. van Pham, ed. Stem cell drugs – a new generation of biopharmaceuticals. Cham: Springer, 143–152.
   Google Scholar
• Tallacchini, M., 2006. Politics of ethics and the EU citizenship. Politeia, XXII (83), 101–113.
   Google Scholar
• Titmuss, R.M., 1970. The gift relationship: from human blood to social policy. London: Allen and Unwin.
   Google Scholar
• Trommelmans, L., Selling, J., and Dierickx, K., 2011. Informed consent when donating cells for the production of human tissue engineered products. In: C. Lenk, N. Hoppe, K. Beier, and C. Wiesemann, eds. Human tissue research. A European perspective on the ethical and legal challenges. Oxford Scholarship Online, 149–156.
   Google Scholar
• Waldby, C. and Mitchell, R., 2006. Tissue economies: blood, organs, and cell lines in late capitalism. Durham, NC: Duke University Press, 31–35.
   Google Scholar